SCHEMBL8477159

SCHEMBL8477159

CC(C)(C)[Si](C)(C)OCc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 5/20 0.38
JAK2 O60674 4/20 0.38
JAK1 P23458 4/20 0.38
GHSR Q92847 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 2/20 0.36
SLC16A3 O15427 1/20 0.36
BACE1 P56817 1/20 0.36
RAB9A P51151 1/20 0.35
PTGES O14684 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
HDAC3 O15379 1/20 0.35
NCOR1 O75376 1/20 0.35
CDK1 P06493 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538571 0.87 SLC16A3 (0.38) TYK2JAK2JAK1GHSRMEN1
SCHEMBL6537516 0.86 SMN1; SMN2 (0.34) TYK2JAK2JAK1GHSRMEN1
SCHEMBL6537695 0.86 PTGES (0.44) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6538065 0.84 GAA (0.42) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537732 0.83 TYK2 (0.42) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6538181 0.82 MEN1 (0.34) TYK2JAK2JAK1GHSRMEN1
SCHEMBL6537957 0.82 TYK2 (0.44) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6538034 0.82 TYK2 (0.45) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537656 0.82 MEN1 (0.32) TYK2JAK2JAK1GHSRMEN1
SCHEMBL6537843 0.80 SLC16A3 (0.42) TYK2JAK2JAK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed